Alfredo Tartarone

Rionero In Vulture, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.

Journal: Immunotherapy

Published: August 24, 2026

CTNNB1 Mutations in Non-small Cell Lung Cancer: Clinicopathological Characteristics of a Small Cohort.

CTNNB1 Mutations in Non-small Cell Lung Cancer: Clinicopathological Characteristics of a Small Cohort.

Journal: Anticancer research

Published: May 04, 2026

Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience.

Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience.

Journal: Anticancer research

Published: February 13, 2026

Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial.

Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial.

Journal: Cancer treatment and research communications

Published: July 22, 2025

Cyclophosphamide and Etoposide: A mathematical evaluation of the decay of two highly reactive molecules.

Cyclophosphamide and Etoposide: A mathematical evaluation of the decay of two highly reactive molecules.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: June 11, 2025

Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.

Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.

Journal: Oncology

Published: May 30, 2025

Application of dihydropyrimidine dehydrogenase deficiency testing for the prevention of fluoropyrimidine toxicity: a real-world experience in a Southern Italy cancer center.

Application of dihydropyrimidine dehydrogenase deficiency testing for the prevention of fluoropyrimidine toxicity: a real-world experience in a Southern Italy cancer center.

Journal: Journal of chemotherapy (Florence, Italy)

Published: April 18, 2025

The value of chromosome 8 heteroploid tumor cells in the peripheral blood and pleural effusion in evaluating treatment efficacy and the prognosis of metastatic non-small cell lung cancer patients.

The value of chromosome 8 heteroploid tumor cells in the peripheral blood and pleural effusion in evaluating treatment efficacy and the prognosis of metastatic non-small cell lung cancer patients.

Journal: Journal of thoracic disease

Published: April 08, 2025

APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer.

APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer.

Journal: NPJ precision oncology

Published: April 03, 2025

Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer.

Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer.

Journal: Translational cancer research

Published: December 16, 2024

Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients.

Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients.

Journal: Frontiers in immunology

Published: December 06, 2024

EGFR Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment?

EGFR Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment?

Journal: Anticancer research

Published: November 26, 2024

Showing 1-12 of 66

Last Updated: 09/26/2026